NLRP3 and colitis: In this study, we aimed to investigate the anti-colitis efficacy of CSCC and explore whether and how Gpr43 inhibits the STAT3/NLRP3 signaling pathway, thereby mediating the protective effects of CSCC on the intestinal barrier.